May. 15, 2020
On May 7, journalist learned from Xiangyang Xiangcheng District Investment Promotion Center, China’s Hubei Province, that a pharmaceutical intermediates project invested in by Shanghai ABA Chemicals
for Yuan500 million, is being set up in Xiangcheng.
Phase one of the amide intermediates project in Xiangcheng covers newly built workshops and supporting facilities for the production of tetraniliprole, triflumezopyrim and etc. After the completion of the project, the annual production value is expected to reach Yuan500 million, with an annual tax contribution of Yuan25 million.
The project, launched by ABA Chemicals this time and chosen to be set up in Xiangcheng, is a complete recognition of Xiangcheng's pharma-chemical industrial strength. The project is expected to further promote the transformation and upgrading of Xiangcheng's pharma-chemical industry through the joint efforts of all the relevant parties.